SCHEMBL7685754

SCHEMBL7685754

N#Cc1ccc2c(c1)C[C@@H](S(=O)(=O)c1cccs1)C(Cc1ccccc1)NN2

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FNTA P49354 11/20 0.43
▸ FNTB P49356 11/20 0.43
▸ PGGT1B P53609 2/20 0.43
▸ HRAS P01112 1/20 0.43
▸ KRAS P01116 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ PSEN1 P49768 1/20 0.33
▸ PSEN2 P49810 1/20 0.33
▸ APH1B Q8WW43 1/20 0.33
▸ NCSTN Q92542 1/20 0.33
▸ APH1A Q96BI3 1/20 0.33
▸ PSENEN Q9NZ42 1/20 0.33
▸ PKM P14618 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ NR3C2 P08235 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7685758 1.00 FNTA (0.43) FNTAFNTBPGGT1BHRASKRAS
SCHEMBL18041271 0.75 FNTA (0.61) FNTAFNTBPGGT1BHRASKRAS
SCHEMBL21877258 0.75 FNTA (0.61) FNTAFNTBPGGT1BHRASKRAS
SCHEMBL18041272 0.75 FNTA (0.61) FNTAFNTBPGGT1BHRASKRAS
SCHEMBL5755053 0.72 FNTA (0.62) FNTAFNTBPGGT1BHRASKRAS
SCHEMBL5790292 0.72 FNTA (0.62) FNTAFNTBPGGT1BHRASKRAS
SCHEMBL6614317 0.69 FNTA (0.58) FNTAFNTBPGGT1BHRASKRAS
SCHEMBL7693749 0.68 FNTA (0.38) FNTAFNTBKMT2A
SCHEMBL7693752 0.68 FNTA (0.38) FNTAFNTBKMT2A
SCHEMBL7693756 0.68 FNTA (0.38) FNTAFNTBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6458783-B1 INHIBITION OF FARNESYL TRANSFERASE, WHICH IS AN ENZYME INVOLVED IN RAS ONCOGENE EXPRESSION, IS EFFECTED BY COMPOUNDS OF THE FORMULAS OF BENODIAZEPINE DERIVATIVES BRISTOL-MYERS SQUIBB COMPANY 2002-10-01 — — US disclosed
Send feedback